Worried about skyrocketing prescription drug costs? Medicare's new spending cap is bringing welcome relief to seniors, with ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...

Adam Gray (D-CA), and Neal Dunn (R-FL) introduced the Protecting Patient Access to Cancer and Complex Therapies Act. This ...

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

As we age, prescription medications often become an essential part of managing our health. Whether it's for controlling blood pressure, treating diabetes or easing arthritis ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

The House passed the “One Big Beautiful Bill Act” on July 3, which includes sweeping changes to healthcare and some pharma-related provisions.

Due to the Inflation Reduction Act of 2022, once coverage kicks in, you won't pay more than a fixed amount for prescription drugs out-of-pocket a year.

The bill would cut $1.1 trillion in health-care spending and result in 11.8 million people losing health coverage over the ...

The pharmaceutical industry’s lobbying muscle scored a high-stakes victory on Monday when the Senate parliamentarian reversed a previous decision and ruled that the Optimizing Research Progress Hope ...